Levin Papantonio announced a landmark settlement agreement with Johnson & Johnson over its tainted talc products, providing a minimum of $5.5 billion to approximately 70,000 sickened women and their families. The settlement resolves claims alleging that Johnson’s Baby Powder and other talc products caused ovarian cancer, mesothelioma, and other serious illnesses. Compensation will be determined through a tiered grid based on objective claim criteria, and because the settlement is uncapped, its total value is not limited to a fixed fund. The agreement remains subject to certain conditions, including participation requirements and enrollment deadlines, and is unanimously supported by the Plaintiffs’ Executive Committee. The settlement follows years of litigation, including three failed Chapter 11 bankruptcy attempts by Johnson & Johnson and a $20 million jury verdict in October 2025.
Johnson & JohnsonLandmark $5.5 billion settlement over talc litigation, resolving claims of cancer from Johnson's Baby Powder.